Skip to content
Back to EVH

Evolent Health, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
2
Purchases
1
Sales
1
Purchase value
$38.20K
Sale value
$329.46K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Daniel Joseph McCarthyPRESIDENT
4Rule 10b5-1 plan disclosed
Filed Aug 28, 2026Period of report Aug 26, 20260001628908-26-000088
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 26, 2026
Class A Common StockF1F265,892$5.00$329.46K655,133Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026.
  2. F2Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Open on SEC EDGAR
Brendan B SpringstubbDirector
4
Filed Nov 19, 2025Period of report Nov 18, 20250001628908-25-000138
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 18, 2025
Class A Common StockF110,000$3.8199$38.20K58,821Direct
Filing footnotes · 1
  1. F1Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.